Satisfaction study of split doses botulinum toxin with double frequency - Split dose double frequency study

Flack Clinic0 个研究点目标入组 96 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•· Males or females, 18 to 65 years of age, inclusive;
•· General good health status
•· Symmetrical rhytids on both sides of the face, expressed by a Merz Aesthetics
•Scales score in dynamic >= 2 in all treatment areas;
•· Client overall satisfaction score >= 2 and <= 8 based on the eVAS Satisfaction
•Scale (0-10);
•· Able to participate and willing to give informed consent and comply with the
•study re-strictions.

•· Clients with known allergies or sensitivity to the drug or any components of
•the study medication;
•· Use of any agent that impedes the neuromuscular transmission, or other
•neuromus-cular diseases that could amplify the effects of botulinum toxin type
•A treatment (e.g. myasthenia gravis, excessive weakness, Eaton-Lambert
•syndrome, or atrophy of target muscles);
•· Previous exposure to botulinum toxin < 6 months before the first treatment;
•· Has ever received a permanent filler in the upper face, or has received a
•temporary filler in the upper face in the last two years;
•· Presence of an infection, or any type of skin disease, in the treatment area;
•· Presence or history of a malignancy like melanoma in the treated area;
•· Grade 4 lines in one re more of the treatment areas expressed by the Merz
•Aesthetic Scales;
•· Marked asymmetry of the crow*s feet by 1 point on the Merz Aesthetic Scales;
•· Females who are pregnant, planning to get pregnant during the full duration
•of the study, or breastfeeding.
•· Clients with body dysmorphic disorder or related diagnosis in the DSM-V.

发起方

Flack Clinic